B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology

Human Pathology

Volumn 41, Issue 5, 2010, Pages 621-631

  Carbone, Antonino ^a   Gloghini, Annunziata ^a   Aiello, Antonella ^a   Testi, Adele ^a   Cabras, Antonello ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

"Gray zone" lymphomas; B cell lymphoma; Borderline lymphomas; Hodgkin lymphoma; Pathogenesis; Pathology

Indexed keywords

ATM PROTEIN; B LYMPHOCYTE ANTIGEN; B LYMPHOCYTE RECEPTOR; CASPASE 2; CD15 ANTIGEN; CD20 ANTIBODY; CD22 ANTIGEN; CD30 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD45 ANTIGEN; CD79B ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; KI 67 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; OCTAMER TRANSCRIPTION FACTOR 2; PHOSPHATIDYLINOSITOL 3 KINASE; PREDNISONE; PROTEIN BCL 2; PROTEIN BCL 6; PROTEIN KINASE B; PROTEIN KINASE LYN; TRANSCRIPTION FACTOR PAX5; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5; VINCRISTINE;

ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CLASSICAL HODGKIN LYMPHOMA; CLINICAL FEATURE; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; ONCOGENE MYC; PATHOGENESIS; PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA; REED STERNBERG CELL; T CELL HISTIOCYTE RICH LARGE B CELL LYMPHOMA; TUMOR CELL;

HUMANS; LYMPHOMA, B-CELL;

EID: 77950550833     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.10.027     Document Type: Article

References (61)

1. Jaffe E.S., Harris N.L., Stein H., and Isaacson P.G. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood 112 (2008) 4384-4399
2. Carbone A., Gloghini A., Serraino D., and Spina M. HIV-associated Hodgkin lymphoma. Curr Opin HIV AIDS 4 (2009) 3-10
3. In: Swerdlow S.H., Campo E., Harris N.L., et al. (Eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008), IARC Press, Lyon, France
4. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). Tumours of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon, France
5. Boudova L., Torlakovic E., Delabie J., et al. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma. Blood 102 (2003) 3753-3758
6. Lim M.S., Beaty M., Sorbara L., et al. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells. Am J Surg Pathol 26 (2002) 1458-1466
7. Zhao F.X. Nodular lymphocyte-predominant Hodgkin lymphoma or T-cell/histiocyte-rich large B-cell lymphoma: the problem in "grey zone" lymphomas. Int J Clin Exp Pathol 1 (2008) 300-305
8. Vanhentenrijk V., Vanden Bempt I., Dierickx D., Verhoef G., Wlodarska I., and De Wolf-Peeters C. Relationship between classic Hodgkin lymphoma and overlapping large cell lymphoma investigated by comparative expressed sequence hybridization expression profiling. J Pathol 210 (2006) 155-162
9. De Wolf-Peeters C., Delabie J., Campo E., Jaffe E.S., and Delsol G. T cell/histiocyte-rich large B-cell lymphoma. In: Swerdlow S.H., Campo E., Harris N.L., et al. (Eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008), IARC, Lyon 238-239
10. Achten R., Verhoef G., Vanuytsel L., and De Wolf-Peeters C. Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features. Histopathology 40 (2002) 31-45
11. Poppema S., Delsol G., Pileri S.A., and Stein H. Nodular lymphocyte predominant Hodgkin lymphoma. In: Swerdlow S.H., Campo E., Harris N.L., et al. (Eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008), IARC, Lyon 323-325
12. Carbone A., Gloghini A., Gruss H.J., and Pinto A. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. Am J Pathol 147 (1995) 912-922
13. Carbone A., Gloghini A., Aldinucci D., Gattei V., Dalla-Favera R., and Gaidano G. Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin's disease. Br J Haematol 117 (2002) 366-372
14. Rudiger T., Jaffe E.S., Delsol G., et al. Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma). Ann Oncol 9 Suppl 5 (1998) S31-S38
15. Brune V., Tiacci E., Pfeil I., et al. Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med 205 (2008) 2251-2268
16. Liso A., Capello D., Marafioti T., et al. Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. Blood 108 (2006) 1013-1020
17. Traverse-Glehen A., Pittaluga S., Gaulard P., et al. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol 29 (2005) 1411-1421
18. Garcia J.F., Mollejo M., Fraga M., et al. Large B-cell lymphoma with Hodgkin's features. Histopathology 47 (2005) 101-110
19. Jaffe E.S., Stein H., Swerdlow S.H., Campo E., Pileri S.A., and Harris N.L. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma. In: Swerdlow S.H., Campo E., Harris N.L., et al. (Eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008), IARC, Lyon 267-268
20. Poppema S., Kluiver J.L., Atayar C., et al. Report: workshop on mediastinal grey zone lymphoma. Eur J Haematol Suppl (2005) 45-52
21. Lamarre L., Jacobson J.O., Aisenberg A.C., and Harris N.L. Primary large cell lymphoma of the mediastinum. A histologic and immunophenotypic study of 29 cases. Am J Surg Pathol 13 (1989) 730-739
22. Pileri S.A., Gaidano G., Zinzani P.L., et al. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. Am J Pathol 162 (2003) 243-253
23. Gaulard P., Harris N.L., Pileri S.A., et al. Primary mediastinal (thymic) large B-cell lymphoma. In: Swerdlow S.H., Campo E., Harris N.L., et al. (Eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008), IARC, Lyon 250-251
24. Ritz O., Leithauser F., Hasel C., et al. Downregulation of internal enhancer activity contributes to abnormally low immunoglobulin expression in the MedB-1 mediastinal B-cell lymphoma cell line. J Pathol 205 (2005) 336-348
25. Rosenwald A., Wright G., Leroy K., et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 198 (2003) 851-862
26. Savage K.J., Monti S., Kutok J.L., et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 102 (2003) 3871-3879
27. Barth T.F., Leithauser F., and Moller P. Mediastinal B-cell lymphoma, a lymphoma type with several characteristics unique among diffuse large B-cell lymphomas. Ann Hematol 80 Suppl 3 (2001) B49-B53
28. Brauninger A., Schmitz R., Bechtel D., Renne C., Hansmann M.L., and Kuppers R. Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma. Int J Cancer 118 (2006) 1853-1861
29. Mancao C., Altmann M., Jungnickel B., and Hammerschmidt W. Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus. Blood 106 (2005) 4339-4344
30. Carbone A., Gloghini A., Cabras A., and Elia G. The Germinal centre-derived lymphomas seen through their cellular microenvironment. Br J Haematol 145 (2009) 468-480
31. Stein H., Delsol G., Pileri S.A., Weiss L.M., Poppema S., and Jaffe E.S. Classical Hodgkin lymphoma, introduction. In: Swerdlow S.H., Campo E., Harris N.L., et al. (Eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008), IARC, Lyon 326-329
32. Chui D.T., Hammond D., Baird M., Shield L., Jackson R., and Jarrett R.F. Classical Hodgkin lymphoma is associated with frequent gains of 17q. Genes Chromosomes Cancer 38 (2003) 126-136
33. Feuerhake F., Kutok J.L., Monti S., et al. NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes. Blood 106 (2005) 1392-1399
34. Guiter C., Dusanter-Fourt I., Copie-Bergman C., et al. Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma. Blood 104 (2004) 543-549
35. Melzner I., Bucur A.J., Bruderlein S., et al. Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line. Blood 105 (2005) 2535-2542
36. Weniger M.A., Melzner I., Menz C.K., et al. Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation. Oncogene 25 (2006) 2679-2684
37. Ritz O., Guiter C., Castellano F., et al. Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma. Blood 114 (2009) 1236-1242
38. Renne C., Willenbrock K., Martin-Subero J.I., et al. High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma. Leukemia 21 (2007) 780-787
39. de Leval L., and Hasserjian R.P. Diffuse Large B-Cell Lymphomas and Burkitt lymphoma. Hematol Oncol Clin North Am 23 (2009) 791-827
40. Kluin P.M., Harris N.L., Stein H., et al. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. In: Swerdlow S.H., Campo E., Harris N.L., et al. (Eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008), IARC, Lyon 265-266
41. Leoncini L., Raphael M., Stein H., Harris N.L., Jaffe E.S., and Kluin P.M. Burkitt lymphoma. In: Swerdlow S.H., Campo E., Harris N.L., et al. (Eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008), IARC, Lyon 262-264
42. Chuang S.S., Ye H., Du M.Q., et al. Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH. Am J Clin Pathol 128 (2007) 558-564
43. Boerma E.G., Siebert R., Kluin P.M., and Baudis M. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of today's knowledge. Leukemia 23 (2009) 225-234
44. Gurbaxani S., Anastasi J., and Hyjek E. Diffuse large B-cell lymphoma-more than a diffuse collection of large B cells: an entity in search of a meaningful classification. Arch Pathol Lab Med 133 (2009) 1121-1134
45. Hyo R., Tomita N., Takeuchi K., et al. The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma. Hematol Oncol (2009)
46. Ci W., Polo J.M., Cerchietti L., et al. The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL. Blood 113 (2009) 5536-5548
47. Saito M., Novak U., Piovan E., et al. BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Proc Natl Acad Sci U S A 106 (2009) 11294-11299
48. Hartmann EM, Ott G, Rosenwald A. Molecular biology and genetics of lymphomas. Hematol Oncol Clin North Am 2008;22:807, 23, vii.
49. Au W.Y., Horsman D.E., Gascoyne R.D., Viswanatha D.S., Klasa R.J., and Connors J.M. The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive cases. Leuk Lymphoma 45 (2004) 519-528
50. Said J. Diffuse aggressive B-cell lymphomas. Adv Anat Pathol 16 (2009) 216-235
51. Haralambieva E., Boerma E.J., van Imhoff G.W., et al. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am J Surg Pathol 29 (2005) 1086-1094
52. Bellan C., Lazzi S., De Falco G., Rogena E.A., and Leoncini L. Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach. Hematol Oncol 27 (2009) 182-185
53. Sevilla D.W., Gong J.Z., Goodman B.K., et al. Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation. Am J Clin Pathol 128 (2007) 981-991
54. Le Gouill S., Talmant P., Touzeau C., et al. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica 92 (2007) 1335-1342
55. Keller C.E., Nandula S., Fisher J., et al. The spectrum of B-cell non-Hodgkin lymphomas with dual IgH-BCL2 and BCL6 translocations. Am J Clin Pathol 130 (2008) 193-201
56. Hasserjian R.P., Ott G., Elenitoba-Johnson K.S., Balague-Ponz O., de Jong D., and de Leval L. Commentary on the WHO classification of tumors of lymphoid tissues (2008): "gray zone" lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma. J Hematop 2 (2009) 89-95
57. Zinzani P.L., Martelli M., Magagnoli M., et al. Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy. Blood 92 (1998) 790-794
58. Calvo K.R., Traverse-Glehen A., Pittaluga S., and Jaffe E.S. Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma. Adv Anat Pathol 11 (2004) 227-238
59. Mead G.M., Barrans S.L., Qian W., et al. A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). Blood 112 (2008) 2248-2260
60. Macpherson N., Lesack D., Klasa R., et al. Small noncleaved, non-Burkitt's (Burkit-like) lymphoma: cytogenetics predict outcome and reflect clinical presentation. J Clin Oncol 17 (1999) 1558-1567
61. McClure R.F., Remstein E.D., Macon W.R., et al. Adult B-cell lymphomas with Burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior. Am J Surg Pathol 29 (2005) 1652-1660